Effects of amphetamine on immune-mediated lung inflammatory response in rats

被引:19
|
作者
Ligeiro-Oliveira, AP
de Araújo, AMF
Lazzarini, R
Silva, ZL
De Nucci, G
Muscará, MN
de Lima, WT
Palermo-Neto, J
机构
[1] Univ Sao Paulo, Sch Vet Med, Appl Pharmacol & Toxicol Lab, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
amphetamine; allergic inflammation; bronchoalveolar lavage; metyrapone; bone marrow; corticosterone; sensitization;
D O I
10.1159/000076767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The present study analyzed the effects of acute amphetamine (AMPH) treatment on immune-mediated lung inflammatory response in rats. Methods: There were four experiments. In the first and second experiments, rats were treated with AMPH (1 mg/kg) or 0.9% NaCl, and locomotor activity (experiment 1) and serum AMPH concentrations (experiment 2) were measured 1 or 12 h after treatment. In the third experiment, rats which were immunized with ovalbumin (OVA) were treated 14 days later with 0.9% NaCl or AMPH (1 mg/kg). Twelve hours after these treatments, all animals were submitted to challenge by 1% OVA inhalation being analyzed afterwards for bronchoalveolar lavage fluid (BAL), peripheral blood and bone marrow cellularity. In the fourth and final experiment, rats were treated and studied as for experiment 3, except that half of the animals within each group were previously treated with metyrapone prior to the OVA challenge. Results: In the nonimmunized rats, AMPH treatment induced an increase in locomotor activity synchronized to high serum AMPH concentrations 1 h after, but not 12 h after treatment. In OVA-challenged rats, AMPH treatment decreased the total number of inflammatory cells, recovered in both BAL and peripheral blood and increased the total number of bone marrow cells. These effects, observed 1 day after OVA challenge, were abrogated by previous metyrapone treatment. Conclusion: AMPH treatment changed HPA-axis responsiveness to the stress condition imposed by the OVA challenge decreasing lung and blood leukocytes cellularity most probably via corticosterone actions on bone marrow activity. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [41] The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses
    Casas, Rosa
    Estruch, Ramon
    Sacanella, Emilio
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (01) : 23 - 35
  • [42] Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
    Marrie, Ruth Ann
    Graff, Lesley
    Walker, John R.
    Fisk, John D.
    Patten, Scott B.
    Hitchon, Carol A.
    Lix, Lisa M.
    Bolton, James
    Sareen, Jitender
    Katz, Alan
    Berrigan, Lindsay I.
    Marriott, James J.
    Singer, Alexander
    El-Gabalawy, Renee
    Peschken, Christine A.
    Zarychanski, Ryan
    Bernstein, Charles N.
    JMIR RESEARCH PROTOCOLS, 2018, 7 (01):
  • [43] Effects of glycyrrhizin on immune-mediated cytotoxicity
    Yoshikawa, M
    Matsui, Y
    Kawamato, H
    Umemoto, N
    Oku, K
    Koizumi, M
    Yamao, JI
    Kuriyama, S
    Nakano, H
    Hozumi, N
    Ishizaka, S
    Fukui, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (03) : 243 - 248
  • [44] Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
    Justin Chau
    Meeta Yadav
    Ben Liu
    Muhammad Furqan
    Qun Dai
    Shailesh Shahi
    Arnav Gupta
    Keri Nace Mercer
    Evan Eastman
    Taher Abu Hejleh
    Carlos Chan
    George J. Weiner
    Catherine Cherwin
    Sonny T. M. Lee
    Cuncong Zhong
    Ashutosh Mangalam
    Jun Zhang
    BMC Cancer, 21
  • [45] Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancerq|
    Chau, Justin
    Yadav, Meeta
    Liu, Ben
    Furqan, Muhammad
    Dai, Qun
    Shahi, Shailesh
    Gupta, Arnav
    Mercer, Keri Nace
    Eastman, Evan
    Hejleh, Taher Abu
    Chan, Carlos
    Weiner, George J.
    Cherwin, Catherine
    Lee, Sonny T. M.
    Zhong, Cuncong
    Mangalam, Ashutosh
    Zhang, Jun
    BMC CANCER, 2021, 21 (01)
  • [46] Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
    Maier, Jeanette A.
    Castiglioni, Sara
    Petrelli, Alessandra
    Cannatelli, Rosanna
    Ferretti, Francesca
    Pellegrino, Greta
    Puttini, Piercarlo Sarzi
    Fiorina, Paolo
    Ardizzone, Sandro
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [47] Immune-mediated Pathogenesis and Therapies for Inflammatory Autoimmune Diseases
    Islam, Md. Asiful
    Kamal, Mohammad A.
    Zulfiker, Abu H. Md
    Gan, Siew H.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (27) : 2907 - 2908
  • [48] Protective Effects of Ursodeoxycholic Acid against Immune-Mediated Liver Fibrosis in Rats
    Zhang, Li-Xin
    Liang, Tie-Jun
    Tan, Yan-Rong
    Ren, Wan-Hua
    Han, Guo-Qing
    Zhang, Jie
    Wang, Lai-Cheng
    Qin, Cheng-Yong
    HEPATO-GASTROENTEROLOGY, 2010, 57 (102-03) : 1196 - 1202
  • [49] Quality of Life in Patients with Immune-Mediated Inflammatory Diseases
    Russell, Anthony S.
    Gulliver, Wayne P.
    Irvine, E. Jan
    Albani, Salvatore
    Dutz, Jan P.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 : 7 - 19
  • [50] Proactive drug monitoring for immune-mediated inflammatory diseases
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 205 - 205